4-122827062-G-C

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2

The NM_002006.6(FGF2):ā€‹c.287G>Cā€‹(p.Arg96Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000019 in 1,102,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.0000068 ( 0 hom., cov: 31)
Exomes š‘“: 0.000021 ( 0 hom. )

Consequence

FGF2
NM_002006.6 missense

Scores

2
5
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.682
Variant links:
Genes affected
FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.2885376).
BS2
High AC in GnomAdExome4 at 20 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FGF2NM_001361665.2 linkuse as main transcriptc.-113G>C 5_prime_UTR_variant 1/3 ENST00000644866.2 NP_001348594.1
FGF2NM_002006.6 linkuse as main transcriptc.287G>C p.Arg96Pro missense_variant 1/3 NP_001997.5 P09038-4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FGF2ENST00000264498.9 linkuse as main transcriptc.287G>C p.Arg96Pro missense_variant 1/31 ENSP00000264498.4 P09038-4A0A0A0MQV6
FGF2ENST00000644866.2 linkuse as main transcriptc.-113G>C 5_prime_UTR_variant 1/3 NM_001361665.2 ENSP00000494222.1 P09038-2
FGF2ENST00000608478.1 linkuse as main transcriptc.-113G>C 5_prime_UTR_variant 1/31 ENSP00000477134.1 P09038-2

Frequencies

GnomAD3 genomes
AF:
0.00000680
AC:
1
AN:
146984
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000151
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000209
AC:
20
AN:
955724
Hom.:
0
Cov.:
30
AF XY:
0.0000223
AC XY:
10
AN XY:
448888
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000214
Gnomad4 OTH exome
AF:
0.0000286
GnomAD4 genome
AF:
0.00000680
AC:
1
AN:
146984
Hom.:
0
Cov.:
31
AF XY:
0.0000140
AC XY:
1
AN XY:
71576
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000151
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 19, 2024The c.287G>C (p.R96P) alteration is located in exon 1 (coding exon 1) of the FGF2 gene. This alteration results from a G to C substitution at nucleotide position 287, causing the arginine (R) at amino acid position 96 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.33
.;T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.46
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.47
T;T
M_CAP
Pathogenic
0.77
D
MetaRNN
Benign
0.29
T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
0.34
.;N
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
0.45
N;.
REVEL
Uncertain
0.37
Sift
Uncertain
0.0010
D;.
Sift4G
Uncertain
0.013
D;D
Polyphen
0.046
.;B
MutPred
0.35
Loss of methylation at R96 (P = 8e-04);Loss of methylation at R96 (P = 8e-04);
MVP
0.74
ClinPred
0.52
D
GERP RS
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.28
gMVP
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1725652120; hg19: chr4-123748217; API